• Something wrong with this record ?

Safety of hydroimplantation: a foldable intraocular lens implantation without the use of an ophthalmic viscosurgical device

P. Studeny, M. Hyndrak, M. Kacerovsky, P. Mojzis, D. Sivekova, P. Kuchynka,

. 2014 ; 24 (6) : 850-6.

Language English Country Italy

Document type Comparative Study, Journal Article, Randomized Controlled Trial

PURPOSE: To compare the safety of a single-piece, foldable intraocular lens (IOL) hydroimplantation with that of a standard implantation using an ophthalmic viscosurgical device (OVD). METHODS: One hundred consecutive patients with bilateral age-related cataract surgery were enrolled into a prospective double-blind study. Each patient's first eye was randomly assigned to a standard implantation technique with an OVD or the hydroimplantation technique, while the fellow eye received the opposite technique. The main outcomes measured were endothelial cell loss, postoperative changes of intraocular pressure (IOP), and the frequency of complications. RESULTS: The reduction of endothelial cell density 1 month and 6 months after the surgery was 9.76% ± 13.5%, 10.7% ± 12.6%, respectively, in group A (OVD) and 9.07% ± 12.7%, 9.13% ± 13.7%, respectively, in group B (hydroimplantation). The differences were not statistically significant. The mean IOP 2 hours after surgery was 10.19 ± 6.78 mm Hg in group A and 9.92 ± 7.01 mm Hg in group B. Twenty-four hours and 1 month after surgery, the mean IOP was 14.52 ± 5.59 mm Hg and 13.21 ± 3.5 mm Hg, respectively, in group A, and 15.45 ± 5.77 mm Hg and 13.1 ± 3.44 mm Hg, respectively, in group B. The differences between groups A and B were not statistically significant. CONCLUSIONS: The hydroimplantation technique is a safe technique for single-piece foldable IOL implantation. There was no increase in intraoperative and postoperative complications compared with the standard implantation technique using an OVD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008047
003      
CZ-PrNML
005      
20150324100736.0
007      
ta
008      
150306s2014 it f 000 0|eng||
009      
AR
024    7_
$a 10.5301/ejo.5000491 $2 doi
035    __
$a (PubMed)24846622
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Studeny, Pavel $u Eye Clinic Somich, Karlovy Vary - Czech Republic.
245    10
$a Safety of hydroimplantation: a foldable intraocular lens implantation without the use of an ophthalmic viscosurgical device / $c P. Studeny, M. Hyndrak, M. Kacerovsky, P. Mojzis, D. Sivekova, P. Kuchynka,
520    9_
$a PURPOSE: To compare the safety of a single-piece, foldable intraocular lens (IOL) hydroimplantation with that of a standard implantation using an ophthalmic viscosurgical device (OVD). METHODS: One hundred consecutive patients with bilateral age-related cataract surgery were enrolled into a prospective double-blind study. Each patient's first eye was randomly assigned to a standard implantation technique with an OVD or the hydroimplantation technique, while the fellow eye received the opposite technique. The main outcomes measured were endothelial cell loss, postoperative changes of intraocular pressure (IOP), and the frequency of complications. RESULTS: The reduction of endothelial cell density 1 month and 6 months after the surgery was 9.76% ± 13.5%, 10.7% ± 12.6%, respectively, in group A (OVD) and 9.07% ± 12.7%, 9.13% ± 13.7%, respectively, in group B (hydroimplantation). The differences were not statistically significant. The mean IOP 2 hours after surgery was 10.19 ± 6.78 mm Hg in group A and 9.92 ± 7.01 mm Hg in group B. Twenty-four hours and 1 month after surgery, the mean IOP was 14.52 ± 5.59 mm Hg and 13.21 ± 3.5 mm Hg, respectively, in group A, and 15.45 ± 5.77 mm Hg and 13.1 ± 3.44 mm Hg, respectively, in group B. The differences between groups A and B were not statistically significant. CONCLUSIONS: The hydroimplantation technique is a safe technique for single-piece foldable IOL implantation. There was no increase in intraoperative and postoperative complications compared with the standard implantation technique using an OVD.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a úbytek endoteliálních buněk rohovky $x patologie $7 D055954
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nitrooční tlak $x fyziologie $7 D007429
650    _2
$a peroperační komplikace $7 D007431
650    _2
$a implantace nitrooční čočky $x metody $7 D019654
650    12
$a nitrooční čočky $7 D007910
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a fakoemulzifikace $x metody $7 D018918
650    _2
$a pooperační komplikace $7 D011183
650    _2
$a prospektivní studie $7 D011446
650    _2
$a tonometrie oční $7 D014065
650    _2
$a viskosuplementace $x metody $7 D055676
650    _2
$a viskosuplementy $x aplikace a dávkování $7 D055675
650    _2
$a zraková ostrost $x fyziologie $7 D014792
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Hyndrak, Michal
700    1_
$a Kacerovsky, Martin
700    1_
$a Mojzis, Peter
700    1_
$a Sivekova, Deli
700    1_
$a Kuchynka, Pavel
773    0_
$w MED00180219 $t European journal of ophthalmology $x 1724-6016 $g Roč. 24, č. 6 (2014), s. 850-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24846622 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150324101024 $b ABA008
999    __
$a ok $b bmc $g 1065320 $s 890847
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 24 $c 6 $d 850-6 $i 1724-6016 $m European journal of ophthalmology $n Eur J Ophthalmol $x MED00180219
LZP    __
$a Pubmed-20150306

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...